Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 10452
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536306(3-(2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl...)
Affinity DataIC50: 1.5nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536304((E)-2-(5-((4-(2-hydroxyethyl)piperidin-1-yl)sulfon...)
Affinity DataIC50: 1.60nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536316(2-(2-ethoxy-5-((4-(3-hydroxypropyl)piperazin-1-yl)...)
Affinity DataIC50: 2.80nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536307(2-(2-ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)s...)
Affinity DataIC50: 4.10nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536314((E)-2-(2-ethoxy-5-((4-(3-hydroxypropyl)piperazin-1...)
Affinity DataIC50: 4.20nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536310((E)-2-(2-ethoxy-5-((4-(2-hydroxyethyl)piperidin-1-...)
Affinity DataIC50: 4.80nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536303((E)-5-methyl-2-(5-((4-methylpiperazin-1-yl)sulfony...)
Affinity DataIC50: 5.30nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM14390(SILDENAFIL CITRATE | Sildenafil# | CHEMBL192 | 5-[...)
Affinity DataIC50: 5.40nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536315((E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50: 12nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536302(2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)ph...)
Affinity DataIC50: 12nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536301((E)-2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfony...)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandPNGBDBM536313((E)-2-(1-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50: 66nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent